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Mutations in WD40-repeat protein 62 (WDR62) are commonly associated with primary microcephaly and other developmental
cortical malformations. We used human pluripotent stem cells (hPSC) to examine WDR62 function during human neural
differentiation and model early stages of human corticogenesis. Neurospheres lacking WDR62 expression showed decreased
expression of intermediate progenitor marker, TBR2, and also glial marker, S100β. In contrast, inhibition of c-Jun N-terminal
kinase (JNK) signalling during hPSC neural differentiation induced upregulation of WDR62 with a corresponding increase in
neural and glial progenitor markers, PAX6 and EAAT1, respectively. These findings may signify a role of WDR62 in specifying
intermediate neural and glial progenitors during human pluripotent stem cell differentiation.
1. Introduction
WD40-repeat protein 62 (WDR62) mutations are common
genetic causes of human autosomal recessive primary micro-
cephaly (MCPH), a neurodevelopmental disorder character-
ized by significantly reduced cerebral cortex size at birth [1].
WDR62 mutations have also been implicated in several other
cortical malformations, suggesting pleiotropic functions dur-
ing brain development [2, 3]. Wdr62 is a microtubule-
associated scaffold protein that is regulated by tiered c-Jun
N-terminal kinase (JNK) signalling modules [4, 5]. Wdr62
studies involving embryonic mouse brains and human cell
lines demonstrate its dynamic cell cycle-dependent spindle
pole localization and mitotic function [3, 6]. Knockdown of
Wdr62 expression in rat embryos disturbs cell division of
neural progenitors in the ventricular (VZ) and subventricular
(SVZ) zones, resulting in decreased proliferation and
premature differentiation [4]. Other studies examining
Wdr62 mutant mice attributed the reduction of neural pro-
genitors to increased cell death resulting from cell cycle arrest
rather than altered differentiation of progenitors [7]. Taken
together, these studies support a role for WDR62 in neuro-
genesis during brain development although the precise role
and range of WDR62 functions remain unclear [2–4, 8, 9].
While studies in mice and immortalized cell lines have
greatly contributed to our understanding of WDR62’s role
in neurogenesis, it is important to further investigate its func-
tion within the context of human model systems. Human
pluripotent stem cells (hPSC) may be utilised to model pro-
cesses associated with cortical development and related neu-
rodevelopmental disorders in vitro [10, 11]. Accordingly,
here, we investigated the role of WDR62 in specification to
neural and astrocyte progenitors via using an inducible
WDR62-depleted hPSC line and implementation of well-
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established protocols that generate cortical neural and glial
progenitors. Our findings show that downregulation of
WDR62 leads to reduction in intermediate neural and glial
progenitors derived from hPSC. Consistent with these find-
ings, specific inhibition of JNK signalling in hPSC-derived
neural cultures enhanced expression of WDR62, giving rise
to an increase in neural and glial progenitors. Taken together,
these findings suggest that WDR62 is required for specifica-
tion of early neural and glial progenitors and a role for JNK
signalling in negatively regulating WDR62 in hPSC.
2. Materials and Methods
2.1. Maintenance of hPSC and Generation of shRNA
Knockdown Lines. This project is approved by the University
of Melbourne Human Ethics committee (number 1545384).
The H9 (WA-09, WiCell) cell line was a cultured feeder free
on vitronectin-coated plates using MTeSR-1 defined media
according to the manufacturer’s instructions (Stem Cell
Technologies) and maintained at 37°C 5% CO2. Colonies
were mechanically dissected every 7 days and transferred
to freshly coated plates. Cell culture media were changed
every day.
shRNA knockdown was performed using SMARTchoice
inducible lentiviral small hairpin RNA (shRNA) targeting
human WDR62 (H15) (Dharmacon, catalog number:
VSH6376). H9 cells were plated on organ culture dish and
were transduced as per manufacturer’s instructions at MOI
of 0.5 and selected using 0.5μg/mL puromycin. At day 7,
transduced hPSC (hPSC-H15) were temporarily treated with
1μg/ml doxycycline (Dox) to induce expression of GFP and
further perform manual selection.
2.2. Neural and Glial Differentiation. Neural induction of H9
cells and/or WDR62 shRNA-transduced H9 cells were set
up as described by Denham and Dottori, with some slight
modifications [12]. hPSC and/or hPSC-H15 were mechani-
cally dissected into pieces approximately 0.5mm in width
and transferred to laminin-coated organ culture plates in
N2B27 medium containing 1 : 1 mix of neurobasal medium
with DMEM/F12 medium, supplemented with 1% insulin/
transferrin/selenium, 1% N2, 1% retinol-free B27, 0.3%
glucose, 25U/ml penicillin, and 25μg/ml streptomycin (Life
Technologies/Invitrogen). For differentiation to cortical
neurons, the small molecule inhibitor SB431542 (10μM,
Tocris) and noggin (500 ng/ml, Peprotech) were added to
the media for the first 7 days followed by the addition of
fibroblast growth factor (FGF) (20 ng/ml, Peprotech) for
the remaining 7 days. Following 2 weeks of neural induction,
neural progenitors were mechanically harvested and cul-
tured in suspension in neural basal media (NBM) supple-
mented with FGF (20ng/ml, Peprotech) and epidermal
growth factor (EGF) (20 ng/ml, Peprotech) to promote neu-
rosphere (NSP) formation [13]. To differentiate to glial cells,
pieces of neural induction colonies were plated onto
fibronectin-coated organ culture plates containing NBM sup-
plemented with FGF (20ng/ml, Peprotech), EGF (20ng/ml,
Peprotech), and PDGF-AA (20 ng/ml, Peprotech) for one
week followed by an additional week without supplements.
shRNA-transduced hPSC cells were constantly treated with
0.5μg/mL puromycin. Dox treatment commenced from the
beginning of the induction with no Dox controls set up in
parallel. Media change was performed every second day. At
the end of the experiment, samples were either fixed and pre-
pared for immunostaining or processed for real-time quanti-
tative PCR (Q-PCR) expression analyses.
2.3. Immunostaining. Cell monolayers and NSPs were fixed
in 4% PFA for 20 minutes at 4°C and then washed briefly
in PBS. NSPs were embedded in Tissue-Tek OCT compound
(Labtek) and cut at 15μm on a cryostat, and sections were
placed on superfrost slides. After washing in PBS, sections
or culture dishes were permeabilized with 0.1% Triton-X-
100 in PBS (PBT) for 5 minutes and then blocked in 10% fetal
calf serum in PBT for 60 minutes at room temperature. Sam-
ples were then incubated with primary antibody (diluted in
the block buffer) overnight at 4°C. The following primary
antibodies were used: goat anti-SOX2 (1 : 200, R&D Systems),
mouse anti-PAX6 (1 : 80, DSHB), rabbit anti-TBR2 (1 : 1000,
Chemicon), mouse anti-TUJ1 (1 : 1000, Millipore), rabbit
anti-KI67 (1 : 600, Abcam), and mouse anti-S100β (1 : 500,
Sigma). Following three 5 minute washes in PBT, ALEXA
Fluor secondary antibodies (Life Technologies/Invitrogen)
(1 : 1000 diluted in the block buffer) were applied for 1 hour
at room temperature. All samples were counterstained with
49,6-diamidino-2-phenylindole (DAPI; 1μg/ml, Sigma-
Aldrich). Samples were then mounted onto glass slides with
5μl of moviol aqueous mountant followed by viewing and
image capturing under Zeiss Axio Observer z1 fluorescence
microscope using ZEN imaging software.
2.4. Gene Expression Analysis. Cells were harvested and proc-
essed for total RNA extraction using PureLink RNAMini Kit
(Life Technologies). Quality of RNA was examined on Nano-
Drop 2000 Spectrophotometer (Thermo Scientific) with
A260/280 ratio ranging from 1.95 to 2.05. Up to 2μg of RNA
was used to synthesize first-strand cDNA using SensiFAST
cDNA Synthesis Kit (Bioline). Q-PCR reaction and data col-
lection was performed on ViiA7 Real-Time PCR System (Life
Technologies) using Universal Master Mix (Applied Biosys-
tems), and raw data were exported to Microsoft Excel for fur-
ther analysis. Cycling parameters were as follows: 50°C for 2
minutes, 95°C for 10 minutes to activate DNA polymerase,
then 40 cycles of 95°C for 15 seconds, and 60°C for 1 minute.
ΔCT values were obtained by normalization to the mean of
three internal reference genes GAPDH, HMBS, and ELF1.
Next, ΔΔCT values were obtained by normalization to ΔCT
values of appropriate control samples. Relative gene expres-
sion values (fold change) were then calculated using the
2−ΔΔCT method [14]. Statistical significance tests were per-
formed using unpaired t-test and one-way ANOVA with
post hoc Bonferroni multiple comparisons.
2.5. NSP Size Measurements. To compare the size of hPSC-
H15-derived NSPs treated with Dox versus no Dox treat-
ment, for each independent experiment (n = 4), brightfield
images were randomly taken for at least 3 NSPs for each con-
dition using Zeiss Axio Observer z1 fluorescence microscope
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and ZEN imaging software. All images were taken at a consis-
tent magnification for each experiment. ImageJ software was
used to estimate the largest diameter of each NSP, briefly, by
manually drawing a straight line across the centre of the NSP
and the length of which was documented in μm. Statistical
significance tests were performed using Mann–Whitney test.
2.6. Quantification of S100β. WDR62 shRNA-transduced
hPSC underwent glial differentiation for 2 weeks and then
processed for immunofluorescence staining of S100β as
described above. S100β-positive neurons in Dox treated and
no Dox treatment were analysed from at least 3 replicates.
Images for analysis were taken using 20x objective Zeiss Axio
Observer z1 fluorescence microscope and ZEN imaging soft-
ware. ImageJ software was used to quantify integrated density
of S100β staining within images for each replicate. The
results from Dox treated were compared to the normalized
results obtained from the no Dox group (set at 100%). Two-
tailed t-test was used to determine statistical significance.
2.7. JNK Inhibition. JNK inhibitor was obtained from EMD
Millipore (catalog number: 420135), reconstituted in
dimethyl sulfoxide (DMSO) to 50mM, and used at 50μM.
H9 neural inductions were treated with JNK inhibitor from
day 0 of neural induction, and DMSO-treated control was
always set up in parallel. The experiment was conducted at
least three times. Cultures were harvested for Q-PCR analy-
ses. Two-tailed t-test was used to determine statistical
significance.
3. Results
3.1. WDR62 Is Expressed during Neural Induction Coinciding
with Early Neural Progenitors. To determine whether
WDR62 was upregulated during hPSC neural differentiation,
endogenous WDR62 expression was measured by Q-PCR
during stages of hPSC neural induction and differentiation
to neural and glial progenitors. The protocol used for neural
induction was the dual SMAD inhibition which involves
treating hPSC with inhibitors of the bone morphogenic pro-
tein and/or activin/nodal signalling pathways, noggin, and
SB431542, respectively, for 7 days followed by FGF for
another 7 days [15]. hPSC-derived progenitors were organize
in a rosette-like morphology expressing early telencephalic
progenitor marker PAX6 and intermediate progenitor
marker TBR2 (Figure 1). Neural progenitors are mechani-
cally harvested and cultured in a suspension supplemented
with FGF and EGF for one week to form NSP aggregates.
NSPs cultured for one week consisted of mixed populations
of early intermediate and postmitotic neural and glial pro-
genitors as indicated by expression of SOX2, PAX6, TBR2,
TUJ1, and S100β (Figure 1) [16, 17].
WDR62 expression was significantly upregulated during
early stages of neural induction at day 7 (ANOVA,
P < 0 05, n = 5), which co-coincided with the onset of SOX2
and PAX6 expression (Figure 1(f)). WDR62 expression was
then significantly reduced at the end of neural induction
(ANOVA, P < 5 0E− 03, n = 5) and also at the NSP stage
(ANOVA, P < 5 0E− 03, n = 5), which corresponded with
an increase in expression of TBR2, TUJ1, EAAT1, and
S100β (Figure 1(f)). These findings suggest that WDR62 is
upregulated at the onset of hPSC neural induction, correlat-
ing with specification of early neural progenitors.
3.2. Inducible Knockdown of WDR62 Expression during hPSC
Neural Induction. Given that WDR62 expression was upreg-
ulated at the early stages of neural induction, we explored
the impact of reduced WDR62 expression on hPSC neural
differentiation. For these analyses, hPSC were transduced
with WDR62 Dox-inducible lentiviral shRNA construct
(H15), which coexpress GFP. hPSC-H15 underwent neural
induction and differentiation using the dual SMAD inhibi-
tion protocol, as previously described, either in the presence
or absence of doxycycline (Dox/no Dox) (Figure 2). Treat-
ment with Dox efficiently induced universal GFP expres-
sion in hPSC-H15-derived neural progenitors at the neural
induction stage, and GFP expression was maintained in 1-
week-old NSPs (Figure 2(b)). At the neural induction stage,
Dox-treated hPSC-H15 exhibited significant mean reduction
(40%) in the expression of WDR62 relative to no Dox treat-
ment (two-tailed t-test, P = 0 04, n = 4) (Figure 2(c)). Simi-
larly at the NSP stage, WDR62 expression was reduced by
more than 70% in Dox-treated hPSC-H15-derived NSPs
compared to no Dox-treated NSPs (two-tailed t-test,
P = 7 3E− 6, n = 6) (Figure 2(c)). Although NSPs were gener-
ated in conditions with reduced WDR62 expression, their
size was significantly smaller than the no Dox-treated con-
trols (Mann–Whitney U test, P = 0 03) (Figure 2(d), Supple-
mental Table 1 available online at https://doi.org/10.1155/
2017/7848932). Overall, these results confirm that the Dox
induction of WDR62 shRNA was effective at reducing
endogenous WDR62 expression in hPSC-derived neural
stem cells and progenitors.
3.3. Downregulation of WDR62 during Neural Differentiation
Reduced Early Neural and Glial Progenitors. To investigate
further the observed effect of WDR62 depletion resulting in
NSP size reduction, we analysed the expression of neural
stem cell and progenitor markers in Dox-treated hPSC-H15
cultures by Q-PCR at both the neural induction and NSP
stages of differentiation. We did not observe significant
changes in gene expression of proliferation marker KI67 or
cell death marker caspase 3 (CASP3) with reduced WDR62
expression (Figures 3(a) and 3(b)). Expression of mitotically
active neural progenitor markers, SOX2 and PAX6, was also
not significantly changed (Figures 3(a) and 3(b)). In contrast,
expression of TBR2, marker of intermediate neural progeni-
tors, and the glial marker S100β was both significantly
reduced in neural induction cultures (two-tailed test,
P = 8 0E− 04 for TBR2 and P = 0 03 for S100β, n≥ 3) and
NSPs (two-tailed t-test, P = 0 01 for TBR2 and P = 0 01 for
S100β, n≥ 3) following Dox-induced WDR62 knockdown
(Figures 3(a) and 3(b)). Interestingly, reduced TBR2 and
WDR62 expression in NSPs corresponded with a trend
towards increased TUJ1 expression, a marker of postmitotic
neurons (Figure 3(b)). Taken together, these results suggest
a role of WDR62 in hPSC neural differentiation, particularly
in hPSC specification to early neural and glial progenitors.
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Figure 1: Expression of WDR62 in hPSC-derived neural progenitors. (a) Schematic diagram outlining neural induction protocol for deriving
cortical neuronal progenitors. (b-c) DS neural induction protocol generates neural progenitors expressing early neural progenitor markers
SOX2 (b, green) and PAX6 (c, red) and intermediate progenitor marker TBR2 (c, green). DAPI stains of nuclei are also shown. Scale
bars = 50μm. (d-e) hPSC-derived 1-week-old NSPs also express neuronal marker TUJ1 (d, red), proliferative marker KI67 (d, green), and
glial marker S100β (e, red). DAPI stains of nuclei are shown in (e). Scale bars = 75μm. (f) Gene expression analyses of pluripotency
marker OCT4; neural progenitor markers SOX2, PAX6, and TBR2; neuronal marker TUJ; glial markers EAAT1 and S100β; and
proliferative marker KI67 and WDR62 across several time points of the neural induction protocol, including hPSC, day 7 NI, day 14 NI,
and 1-week NSPs (n≥ 4 independent experiments for each time point, >3 NSPs per experiment). Data presented as means± S.E.M. one-
way ANOVA with a post hoc Bonferroni multiple comparison was used to assess significance for each gene, comparing all pairs of time
points. ∗P < 0 05; ∗∗P < 5 0E− 03; ∗∗∗P < 1 0E− 04; ∗∗∗∗P < 1 0E− 05. NI: neural induction; NSPs: neurospheres.
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3.4. WDR62 Is Required for Differentiation to Glial
Populations. To further determine whether reduced WDR62
expression impacted on the differentiation of hPSC to glial
progenitors, hPSC-H15 was differentiated to glia in both
Dox and no Dox treatment conditions. The glial differentia-
tion protocol is similar to the neural induction protocol
described above; however after 14 days cells are passaged onto
fibronectin substrate in media supplemented with FGF, EGF,
and PDGF-AA for one week followed by media without sup-
plements for another week (Figure 4(a)). It was found that
Dox-treated glial differentiation cultures, which had reduced
WDR62 expression, resulted in a significant decrease in the
number of S100β-positive cells compared to controls (two-
tailed t-test, P = 4 9E− 04, n = 3) (Figure 4). This finding fur-
ther supports the requirement of WDR62 for early stages of
hPSC glial differentiation.
3.5. Inhibition of JNK Enhances the Expression of WDR62 and
PAX6. To further investigate the mechanisms underlying
WDR62 function, we examined the contribution of JNK
TGGAAGAAAGACATCGTAG
hEF1훼























































































Figure 2: Efficient knockdown of WDR62 expression in hPSC-derived neural progenitors. (a) Map of inducible lentiviral shRNA vector and
targeted sequence ofWDR62. (b) GFP and corresponding brightfield images ofWDR62 shRNA-transduced hPSC-derived neural progenitors
with versus without Dox treatment at neural induction and NSP stages. (c) Gene expression analyses showing downregulation of WDR62
expression in WDR62 shRNA-transduced hPSC-derived neural progenitors treated with Dox versus no Dox treatment at neural induction
(P = 0 04) and NSP stages (P = 7 3E− 6) (n = 4 and n = 6 independent experiments, resp., >3 NSPs per experiment). Two-tailed t-test was
used to assess significance. (d) Diameter measurements of WDR62 shRNA-transduced hPSC-derived NSPs treated with Dox versus no
Dox controls (n = 3 independent experiments, >3 NSPs per experiment). Mann–Whitney U test was used to assess significance. ∗P < 0 05;
∗∗∗∗P < 5 0E− 05. NI: neural induction; NSPs: neurospheres; Dox: doxycycline.
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activity as WDR62/JNK signalling interactions were previ-
ously shown to play a critical role in cortical development
[4, 18]. Thus, we attenuated JNK activity in our differentia-
tion system with a kinase-specific chemical inhibitor (JNK
inhibitor VIII, 50mM) at doses previously demonstrated to
attenuated WDR62/JNK signalling to downstream substrate
[6]. We then assessed the expression of WDR62 and candi-
date genes related to neural and glial differentiation, cell
death, and proliferation by Q-PCR. Our results indicate sig-
nificantly enhanced expression of WDR62 (two-tailed t-test,
P = 0 02, n = 3) following JNK inhibition, compared to
DMSO-treated control samples (Figure 5). This was accom-
panied by significantly increased expression of PAX6 (two-
tailed t-test, P = 0 01, n = 3) and functional glial marker
EAAT1 (two-tailed t-test, P = 0 04, n = 3) (Figure 5). In addi-
tion, there was a trend towards increased S100β following
JNK inhibition. These findings are consistent with reports
of JNK being a negative regulator ofWDR62mitotic function
and expression and are consistent with the role of WDR62 in
neuro- and gliogenesis [6].
4. Discussion
This study is the first to utilise hPSC-based modelling sys-
tem to investigate the role of WDR62 in neurogenesis. We
show that WDR62 is expressed in hPSC-derived neural
progenitors with the highest expression occurring early in
neural induction coincidingwith theonset of earlyneural pro-
genitor markers SOX2 and PAX6. This is consistent with pre-
vious reports describing Wdr62 expression in precursors
undergoing mitosis in the VZ, SVZ, and cortical plate [4, 8].
Others have also reported expression of WDR62 in
postmitotic neurons [7]. Here, we show that knockdown of
WDR62 expression in hPSC-derived neural cultures resulted
in altered differentiation to early neural and glial progenitors
as indicated by the reduced expression of TBR2 and S100β.
Related to these findings, previous studies in Wdr62 mutant
mice demonstrated cortical defects whereby PAX6 and Tbr2
expression were significantly reduced within the cortical
regions; however, there were no significant differences in
Tbr2 expression specifically within the VZ regions [4, 7].
Accompanied with this depletion of neural progenitors, one
study observed reduced cell proliferation and increased pre-
mature neuronal differentiation while another study reported
mitoticdelayand increasedcell death [4, 7]. Incontrast to these
findings, Jayaraman et al. found an increased ratio of TBR2+/
SOX2+ progenitors and increased Ki67+ PAX6− cells beyond
VZ and SVZs in embryonic day 14 Wdr62 null mice and
reduced overall cortical thickness with no evidence of
increased cell death. This led the authors to conclude that loss
ofWdr62 causes cell fate change specifically in switching from
PAX6 to Tbr2 progenitors with no cell death, resulting in
premature delamination of PAX6 progenitors from VZ [19].
In our studies, we did not observe any differences in markers
of cellular proliferation or cell death in WDR62 knockdown
hPSCcultures, althoughNSPsizewere smaller, suggesting that
only subpopulations of progenitorswere affectedby thedown-
regulation of WDR62. In light of these findings, we propose
that WDR62 is likely to play a critical role in the specification
of early neural and glial progenitors.
During cortical development, PAX6 expressing radial
glial cells residing within the VZ undergo self-renewal and/
or differentiation to give rise to intermediate neural/glial pro-







































































Figure 3: WDR62 knockdown effects hPSC specification to neural and glial progenitors. (a) Q-PCR data suggest significant reduction of
TBR2 (P = 8 0E− 04), S100β (P = 0 03), and CASP3 (P = 0 02) expression in Dox-treated WDR62 shRNA-transduced hPSC-derived
neural progenitors treated with Dox versus no treatment at day 14 neural induction (N≥ 3 independent experiments). Two-tailed t-test
was used to assess significance. (b) Similarly, Q-PCR data suggest significant reduction of TBR2 (P = 0 01) and S100β (P = 0 01)
expression in Dox-treated versus no Dox treatment at the NSP stage (N≥ 3 independent experiments, >3 NSPs per experiment). Two-
tailed t-test was used to assess significance. ∗P < 0 05; ∗∗∗∗P < 5 0E− 05. NI: neural induction; NSPs: neurospheres; Dox: doxycycline.
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Intermediate neural progenitors are identified by the expres-
sion of Tbr2, which divide and differentiate within the SVZ to
produce more neurons [20–22, 24–26]. Similar to cortical
neurons, astrocytes are produced either directly from radial
glia or indirectly from more glial restricted intermediate pro-
genitors within the SVZ [27, 28]. Towards the end of cortical
development, the majority of radial glial cells lose their iden-
tity to differentiate to astrocytes expressing S100β [27, 29,
30]. Given this knowledge, it may be that WDR62 plays a role
in transitioning hPSC-derived PAX6 neural precursors to
intermediate progenitors of neural and glial lineages. Similar
to radial glial cells, there may be hPSC-derived PAX6 precur-
sor subpopulations that bypass the intermediate TBR2
progenitor stage and directly differentiate to postmitotic neu-
rons, which may explain why there were no significant
changes in TUJ1 expression in the WDR62 knockdown
NSPs. Alternatively, or in addition to, WDR62 may play a
role in self-renewal of intermediate neural/glial progenitors,
but not in self-renewal of PAX6 neural precursors. Further
in-depth studies of WDR62 expression and function are
needed to determine the underlying mechanisms of how
WDR62 regulates hPSC neural differentiation. Overall, the
findings from this study shed light on WDR62’s role in
human corticogenesis.
The WDR62 mitotic function has been linked to the
activity of JNK [6, 9]. It has been shown that WDR62 recruits
JNK1 to the spindle microtubules specifically during mitosis
and reciprocally JNK1 regulates WDR62 intercellular distri-
bution. Specifically, JNK phosphorylation of WDR62 nega-
tively regulates the association of WDR62 with the spindle
microtubules [6]. As a result of inhibiting JNK signalling, it
has been shown that the WDR62 microtubules association
was persistent irrespective of the cell cycle stage [6]. Our
results indicate that JNK activity is not required for
WDR62 function with regard to specifying neural and glial
progenitors derived from hPSC. In contrast, treatment with
JNK-specific inhibitor increased WDR62 expression in
hPSC-derived neural progenitors and this coincided with
enhanced expression of PAX6-positive cells and astrocyte
functional marker EAAT1. Thus, our findings indicate that
JNK activity may also negatively regulate the expression
levels of WDR62. Nevertheless, our studies in hPSC-derived
neural progenitors suggest that WDR62 expression is
required for the specification of specific neural and glial
Day 0 7 14
SB + noggin FGF2 Astrocytes
28
Neural induction Differentiation








































Figure 4: WDR62 knockdown effects differentiation to astrocytes. (a) Schematic diagram outlining protocol for hPSC differentiation to
astrocytes. (b) GFP, brightfield, and S100β immunostaining images of WDR62 shRNA-transduced hPSC-derived astrocytes with versus
without Dox treatment at the end of differentiation. DAPI stains of nuclei are shown. Scale bars = 50μm. (c) Quantification analyses of
S100β-positive cells suggesting significantly decreased (P = 4 9E− 04) differentiation to astrocytes in Dox-treated group versus no Dox
treatment controls (n = 3 independent experiments). Two-tailed t-test was used to assess significance. ∗∗∗P < 5 0E− 04. Dox: doxycycline.
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lineages and this does not appear to require JNK signalling
activity, a finding that is contrary to rodent studies.
5. Conclusions
This study demonstrates the robustness of hPSC as a comple-
mentary modelling system investigating the developmental
roles of candidate genes implicated in major brain develop-
mental disorders. Our findings show that downregulation
of WDR62 leads to reduction in intermediate neural and glial
progenitors derived from hPSC. Consistent with these find-
ings, specific inhibition of JNK in hPSC-derived neural cul-
tures enhanced the expression WDR62, giving rise to an
increase in neural and glial progenitors. Taken together,
these findings suggest that WDR62 is required for specifica-
tion of early hPSC-derived neural and glial progenitors.
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